Bracco Imaging announces global agreement with Subtle Medical Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.

Webinar für AiW, MTR und MFA Das Webinar "Spin dich in Form" beinhaltet verschiedene Fallbeispiele sowie hilfreiche Tipps und Tricks zum Thema Schulter-MRT. Jetzt anmelden.

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

Vueway® (Gadopiclenol) erhält positive CHMP-Beurteilung Der CHMP der EMA hat das makrozyklische, hochrelaxierende Vueway® (Gadopiclenol) für Erwachsene und Kinder ab 2 Jahren zugelassen.

Bracco gewinnt EcoVadis Goldmedaille Bracco erhält die EcoVadis-Auszeichnung 2023 in Gold für seine Leistungen in Umweltschutz, Ethik, Arbeits- und Menschenrechten sowie nachhaltiger Beschaffung.

Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

Mehr Transparenz, mehr Service Entdecken Sie die neue Service-Website www.gesundheitspolitik-bracco.de, die über Wissenswertes aus der bildgebenden Diagnostik informiert.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.